454 related articles for article (PubMed ID: 26546690)
1. Trousseau's syndrome: cancer-associated thrombosis.
Ikushima S; Ono R; Fukuda K; Sakayori M; Awano N; Kondo K
Jpn J Clin Oncol; 2016 Mar; 46(3):204-8. PubMed ID: 26546690
[TBL] [Abstract][Full Text] [Related]
2. 2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer.
Farge D; Frere C; Connors JM; Ay C; Khorana AA; Munoz A; Brenner B; Kakkar A; Rafii H; Solymoss S; Brilhante D; Monreal M; Bounameaux H; Pabinger I; Douketis J;
Lancet Oncol; 2019 Oct; 20(10):e566-e581. PubMed ID: 31492632
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of direct oral anticoagulants for the treatment of cancer-associated thrombosis: an update.
Franco-Moreno A; Cabezón-Gutiérrez L; Palka-Kotlowsa M; Villamayor-Delgado M; García-Navarro M
J Thromb Thrombolysis; 2019 Apr; 47(3):409-419. PubMed ID: 30467760
[TBL] [Abstract][Full Text] [Related]
4. Fondaparinux as alternative anticoagulant to warfarin or low-molecular-weight heparin for recurrent venous thrombosis.
Thachil J
Ann Pharmacother; 2014 Mar; 48(3):420-4. PubMed ID: 24473488
[TBL] [Abstract][Full Text] [Related]
5. [Low-molecular-weight heparins for cancer-associated thromboembolism: What place in 2019?].
Debourdeau P; Cossou-Gbeto C; Takam-Sohwe T; Laroche JP
Bull Cancer; 2020 Feb; 107(2):224-233. PubMed ID: 32005356
[TBL] [Abstract][Full Text] [Related]
6. LMWH in cancer patients with renal impairment - better than warfarin?
Bauersachs RM
Thromb Res; 2016 Apr; 140 Suppl 1():S160-4. PubMed ID: 27067971
[TBL] [Abstract][Full Text] [Related]
7. Role of current and emerging antithrombotics in thrombosis and cancer.
Mousa SA
Drugs Today (Barc); 2006 May; 42(5):331-50. PubMed ID: 16801996
[TBL] [Abstract][Full Text] [Related]
8. Treatment of venous thromboembolism in patients with cancer: subgroup analysis of the Matisse clinical trials.
van Doormaal FF; Raskob GE; Davidson BL; Decousus H; Gallus A; Lensing AW; Piovella F; Prins MH; Büller HR
Thromb Haemost; 2009 Apr; 101(4):762-9. PubMed ID: 19350123
[TBL] [Abstract][Full Text] [Related]
9. Potent Anticoagulation Does Not Reduce Venous Thromboembolism in High-Risk Patients.
Tan TL; Foltz C; Huang R; Chen AF; Higuera C; Siqueira M; Hansen EN; Sing DC; Parvizi J
J Bone Joint Surg Am; 2019 Apr; 101(7):589-599. PubMed ID: 30946192
[TBL] [Abstract][Full Text] [Related]
10. Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous Thromboembolism.
Chai-Adisaksopha C; Iorio A; Crowther MA; de Miguel J; Salgado E; Zdraveska M; Fernández-Capitán C; Nieto JA; Barillari G; Bertoletti L; Monreal M;
Am J Med; 2018 Apr; 131(4):430-437. PubMed ID: 29274307
[TBL] [Abstract][Full Text] [Related]
11. Treating patients with venous thromboembolism: initial strategies and long-term secondary prevention.
Huisman MV; Bounameaux H
Semin Vasc Med; 2005 Aug; 5(3):276-84. PubMed ID: 16123915
[TBL] [Abstract][Full Text] [Related]
12. Comparative Effectiveness and Safety of Drug Prophylaxis for Prevention of Venous Thromboembolism After Total Knee Arthroplasty.
Cafri G; Paxton EW; Chen Y; Cheetham CT; Gould MK; Sluggett J; Bini SA; Khatod M
J Arthroplasty; 2017 Nov; 32(11):3524-3528.e1. PubMed ID: 28634095
[TBL] [Abstract][Full Text] [Related]
13. Prevention and treatment of cancer-associated thrombosis.
Ng S; Carrier M
Curr Oncol; 2020 Oct; 27(5):275-278. PubMed ID: 33173380
[TBL] [Abstract][Full Text] [Related]
14. [Trousseau's syndrome: a combination of cancer and hypercoagulability].
Melas N
Lakartidningen; 2020 Apr; 117():. PubMed ID: 34255855
[TBL] [Abstract][Full Text] [Related]
15. Low-molecular-weight heparin in the management of Trousseau's syndrome.
Walsh-McMonagle D; Green D
Cancer; 1997 Aug; 80(4):649-55. PubMed ID: 9264346
[TBL] [Abstract][Full Text] [Related]
16. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
17. Single-center, retrospective evaluation of safety and efficacy of direct oral anticoagulants versus low-molecular-weight heparin and vitamin K antagonist in patients with cancer.
Pritchard ER; Murillo JR; Putney D; Hobaugh EC
J Oncol Pharm Pract; 2019 Jan; 25(1):52-59. PubMed ID: 28825375
[TBL] [Abstract][Full Text] [Related]
18. Management of recurrent venous thromboembolism in cancer patients.
Romualdi E; Ageno W
Thromb Res; 2016 Apr; 140 Suppl 1():S128-31. PubMed ID: 27067966
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of cancer associated thrombosis].
Hindré R; Hamdan A; Pastré J; Planquette B; Sanchez O
Bull Cancer; 2022 May; 109(5):528-536. PubMed ID: 35063183
[TBL] [Abstract][Full Text] [Related]
20. An Update in Anticoagulant Therapy for Patients with Cancer-Associated Venous Thromboembolism.
Martins MA; Silva TF; Fernandes CJ
Curr Oncol Rep; 2023 May; 25(5):425-432. PubMed ID: 36928825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]